The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Solovyev Ya.A.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia, Moscow, Russia

Mitina L.A.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdravsotsrazvitiia Rossii

Alekseev B.Ia.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossii

Stepanov S.O.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossii

Kalpinskiĭ A.S.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossiii

Niushko K.M.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdravsotsrazvitiia Rossii

Koryakin A.V.

N.A. Lopatkin Institute of Urology and Interventional Radiology, Branch, National Medical Radiology Research Center, Ministry of Health of Russia, Moscow, Russia

Kornietskaia A.L.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossii

Bolotina L.V.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdravsotsrazvitiia Rossii

Guts O.V.

FGBU «Moskovskiĭ nauchno-issledovatelskiĭ onkologicheskiĭ institut im. P.A. Gertsena» Minzdrava Rossii

Kaprin A.D.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossii

Dimitrov V.O.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia, Moscow, Russia

Zakharova M.A.

Vishnevsky National Medical Research Center of Surgery, Healthcare Ministry of the Russian Federation Moscow, Russia

Use of the contrast agent in the ultrasound diagnosis of kidney tumors

Authors:

Solovyev Ya.A., Mitina L.A., Alekseev B.Ia., Stepanov S.O., Kalpinskiĭ A.S., Niushko K.M., Koryakin A.V., Kornietskaia A.L., Bolotina L.V., Guts O.V., Kaprin A.D., Dimitrov V.O., Zakharova M.A.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2017;6(5): 37‑43

DOI: 10.17116/onkolog20176537-43

Read: 3460 times

Download PDF (RU)
Contact the author
Table of contents

USE OF THE CONTRAST AGENT IN THE ULTRASOUND DIAGNOSIS OF KIDNEY TUMORS
USE OF THE CONTRAST AGENT IN THE ULTRASOUND DIAGNOSIS OF KIDNEY TUMORS

To cite this article:

Solovyev YaA, Mitina LA, Alekseev BIa, et al. . Use of the contrast agent in the ultrasound diagnosis of kidney tumors. P.A. Herzen Journal of Oncology. 2017;6(5):37‑43. (In Russ.)
https://doi.org/10.17116/onkolog20176537-43

Подписка 2026 Онкология. Журнал им. П.А. Герцена (P.A. Herzen Journal of Oncology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Surgical mana­gement of patients with local recu­rrence of renal cancer. Prognostic factors of survival. P.A. Herzen Journal of Onco­logy. 2025;(3):20-24
The place of stereotactic radiotherapy in the treatment of renal cancer. P.A. Herzen Journal of Onco­logy. 2025;(4):86-90
Features of differential diagnosis of onco­logical pathology at the outpatient stage. Russian Journal of Preventive Medi­cine. 2025;(2):93-95
Abstract:

Kidney cancer ranks third among other genitourinary diseases. Surgery is the standard treatment for kidney cancer. The current possibilities of early diagnosis and a comprehensive approach to treating permit a reduction in mortality due to this disease. Study of the use of contrast agents for focal liver lesions studied well enough. The authors give foreign experience with contrast-enhanced ultrasound in the diagnosis of hepatic and renal lesions and their own experience with the contrast agent Sonovue used in the diagnosis of kidney tumors.

Keywords:

contrast-enhanced ultrasound in the diagnosis of the kidney
renal cancer
the contrast agent

Authors:

Solovyev Ya.A.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia, Moscow, Russia

Mitina L.A.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdravsotsrazvitiia Rossii

Alekseev B.Ia.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossii

Stepanov S.O.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossii

Kalpinskiĭ A.S.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossiii

Niushko K.M.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdravsotsrazvitiia Rossii

Koryakin A.V.

N.A. Lopatkin Institute of Urology and Interventional Radiology, Branch, National Medical Radiology Research Center, Ministry of Health of Russia, Moscow, Russia

Kornietskaia A.L.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossii

Bolotina L.V.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdravsotsrazvitiia Rossii

Guts O.V.

FGBU «Moskovskiĭ nauchno-issledovatelskiĭ onkologicheskiĭ institut im. P.A. Gertsena» Minzdrava Rossii

Kaprin A.D.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossii

Dimitrov V.O.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia, Moscow, Russia

Zakharova M.A.

Vishnevsky National Medical Research Center of Surgery, Healthcare Ministry of the Russian Federation Moscow, Russia

Close metadata

References:

  1. Lipworth L, Tarone RE, Lund L, McLaughlin JK. Epidemiologic characteristics and risk factors for renal cell cancer. Clin Epidemiol. 2009;1:33-43. https://doi.org/10.2147/clep.s4759
  2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. Ca Cancer J Clin. 2008;58(2):71-96. https://doi.org/10.3322/ca.2007.0010
  3. National Cancer Institute DCCPS, Surveillance Research Program, Cancer Statistics Branch. SEER Program 17 Registries Public Use Tapes (1973—2005, varying), November 2007 Submission, Released April 2008. https://doi.org/10.1002/jso.23568
  4. La Vecchia C, Negri E, D’Avanzo B, Franceschi S.Smoking and renal cell carcinoma. Cancer Res. 1990;50(17):5231-5233.
  5. Lindgren AM, Nissinen AM, Tuomilehto JO, Pukkala E. Cancer pattern among hypertensive patients in North Karelia, Finland. J Hum Hypertens. 2005;19(5):373-379. https://doi.org/10.1038/sj.jhh.1001834
  6. Pischon T, Lahmann PH, Boeing H, Tjønneland A, Halkjaer J, Overvad K et al. Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2006;118(3):728-738.
  7. McLaughlin JK, Lipworth L, Tarone RE. Epidemiologic aspects of renal cell carcinoma. Semin Oncol. 2006;33(5):527-533. https://doi.org/10.1053/j.seminoncol.2006.06.010
  8. Brennan P, van der Hel O, Moore LE, Zaridze D, Matveev V, Holcatova I, Janout V, Kollarova H, Foretova L, Szeszenia-Dabrowska N, Mates D, Rothman N, Boffetta P, Chow WH. Tobacco smoking, body mass index, hypertension and kidney cancer risk in central and eastern Europe. Br J Cancer. 2008;99(11):1912-1915. https://doi.org/10.1038/sj.bjc.6604761
  9. Pan SY, DesMeules M, Morrison H, Wen SW; The Canadian Cancer Registries Epidemiology Group. Obesity, high energy intake, lack of physical activity and the risk of kidney cancer. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2453-2460. https://doi.org/10.1158/1055-9965.epi-06-0616
  10. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4(8):579-591. https://doi.org/10.1038/nrc1408
  11. Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst. 2000;92(18):1472-1489. https://doi.org/10.1093/jnci/92.18.1472
  12. Weikert S, Boeing H, Pischon T, et al. Blood pressure and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition. Am J Epidemiol. 2008;167(4):438-446. https://doi.org/10.1093/aje/kwm321
  13. Weikert S, Boeing H, Pischon T, Olsen A, Tjonneland A, Overvad K, et al. Fruits and vegetables and renal cell carcinoma: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer. 2006;118(12):3133-3139. https://doi.org/10.1016/s1569-9056(06)60034-1
  14. Rodríguez-Cabello MA, Laso-García I, Donis-Canet F, Gómez-Dos-Santos V, Varona-Crespo C, Burgos-Revilla FJ. Renal cell carcinoma with vascular invasion: mortality and prognostic factors. Actas Urol Esp. 2017;41(2):132-138. https://doi.org/10.1016/j.acuro.2016.06.007
  15. Wagner B, Patard JJ, Méjean A, Bensalah K, Verhoest G, Zigeuner R, Ficarra V, Tostain J, Mulders P, Chautard D, Descotes JL, de la Taille A, Salomon L, Prayer-Galetti T, Cindolo L, Valéri A, Meyer N, Jacqmin D, Lang H. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma. Eur Urol. 2009;55(2):452-459. https://doi.org/10.1016/j.eururo.2008.07.053
  16. Lambert EH, Pierorazio PM, Shabsigh A, Olsson CA, Benson MC, McKiernan JM. Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus. Urology. 2007;69(6):1054-1058. https://doi.org/10.1016/j.urology.2007.02.052
  17. Mano R, Hakimi AA, Sankin AI, Sternberg IA, Chevinsky MS, Russo P. Surgical treatment of tumors involving kidneys with fusion anomalies — a contemporary series. Urology. 2016;98:97-102. https://doi.org/10.1016/j.urology.2016.07.034
  18. Gill IS, Matin SF, Desai MM, Kaouk JH, Steinberg A, Mascha E, Thornton J, Sherief MH, Strzempkowski B, Novick AC. Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients. J Urol. 2003;170(1):64-68.
  19. Gill IS, Kavoussi LR, Lane BR, Blute ML, Babineau D, Colombo JR Jr, Frank I, Permpongkosol S, Weight CJ, Kaouk JH, Kattan MW, Novick AC. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol. 2007;178(1):41-46. https://doi.org/10.1016/j.juro.2007.03.038
  20. Ahmad AE, Finelli A, Jewett MA. Surveillance of small renal masses. Urology. 2016;98:8-13. https://doi.org/10.1016/j.urology.2016.06.005
  21. Atalar E, Ménard C. MR-guided interventions for prostate cancer. Magn Reson Imaging Clin N Am. 2005;13(3):491-504. https://doi.org/10.1016/j.mric.2005.04.012
  22. Simpfendörfer T, Gasch C, Hatiboglu G, Mueller M, Maier-Hein L, Hohenfellner M, Teber D. Intraoperative CT-imaging for navigated laparoscopic renal surgery: first clinical experience. J Endourol. 2016;30(10):1105-1111. https://doi.org/10.1089/end.2016.0385
  23. Nakajima R, Abe K, Kondo T, Nagashima Y, Kimura K, Fukushima K, Momose M, Kondo C, Tanabe K, Sakai S. FDG-PET/CT and CT findings of a benign solitary fibrous tumor of the kidney; correlation with pathology. Asia Ocean J Nucl Med Biol. 2015;3(2):116-119. https://doi.org/10.1007/s00330-015-4026-3
  24. Fu Z, Li Z, Huang J, Zhang J, Liu M, Li Q, Li Y. High (18)F-FDG uptake in urinary calculi on PET/CT: An unrecognized non-malignant accumulation. Eur J Radiol. 2016;85(8):1395-1399. https://doi.org/10.1016/j.ejrad.2016.05.010
  25. Song L, Zhang W, Zhang Y. (18)F-FDG PET/CT imaging of malignant hepatic solitary fibrous tumor. Clin Nucl Med. 2014;39(7):662-664. https://doi.org/10.1097/rlu.0000000000000431
  26. Cornelis F, Ambrosetti D, Rocher L, Derchi LE, Renard B, Puech P, Claudon M, Rouvière O, Ferlicot S, Roy C, Yacoub M, Grenier N, Bernhard JC. CT and MR imaging features of mucinous tubular and spindle cell carcinoma of the kidneys. A multi-institutional review. Eur Radiol. 2016; Jun 22. https://doi.org/10.1007/s00330-016-4469-1
  27. Yang Y, Zhang J, Huan Y, Xu J. CT of a renal mucinous tubular and spindle cell carcinoma. Quant Imaging Med Surg. 2012;2(4):292-293.
  28. Al Harbi F, Tabatabaeefar L, Jewett MA, Finelli A, O’Malley M, Atri M. Enhancement threshold of small (< 4 cm)solid renal masses on CT. AJR Am J Roentgenol. 2016;206(3):554-558. https://doi.org/10.2214/ajr.15.14806
  29. Klein JA, Gonzalez SA, Fischbach BV, Yango AF, Rajagopal A, Rice KM, Saim M, Barri YM, Melton LB, Klintmalm GB, Chandrakantan A. Routine ultrasonography surveillance of native kidneys for renal cell carcinoma in kidney transplant candidates. Clin Transplant. 2016;30(8):946-953. https://doi.org/10.1111/ctr.12769
  30. Voigt JU. Ultrasound molecular imaging. Methods. 2009;48:92-97. https://doi.org/10.1016/j.ymeth.2009.03.011
  31. Schmitz G. Ultrasound in medical diagnosis. In: Pike R, Sabatier P, eds. Scattering: scattering and inverse scattering in pure and applied science. London: Academic Press; 2002:162-174. https://doi.org/10.1016/b978-012613760-6/50010-3
  32. Guan J, Matula TJ. Using light scattering to measure the response of individual ultrasound contrast microbubbles subjected to pulsed ultrasound in vitro. J Acoust Soc Am. 2004;116:2832-2842. https://doi.org/10.1121/1.1795334
  33. Postema M. Fundamentals of medical ultrasonics. London: Spon Press; 2011.
  34. Allen JS, May DJ, Ferrara KW. Dynamics of therapeutic ultrasound contrast agents. Ultrasound Med Biol. 2002;28(6):805-816. https://doi.org/10.1016/s0301-5629(02)00522-7
  35. Wells PNT. Ultrasonic imaging of the human body. Rep Prog Phys. 1999;62:671-722. https://doi.org/10.1088/0034-4885/62/5/201
  36. Burstein DM, Schwartz MM, Korbet SM. Percutaneous renal biopsy with the use of real-time ultrasound. Am J Nephrol. 1991;11:195-200. https://doi.org/10.1159/000168303
  37. Ginsburg JC, Fransman SL, Singer MA, Cohanim M, Morrin PA. Use of computerized tomography to evaluate bleeding after renal biopsy. Nephron. 1980;26:240-243. https://doi.org/10.1159/000181992
  38. Huraib S, Goldberg H, Katz A, Cardella CJ, deVeber GA, Cook GT, Uldall PR. Percutaneous needle biopsy of the transplanted kidney: technique and complications. Am J Kidney Dis. 1989;14:13-17. https://doi.org/10.1016/s0272-6386(89)80087-3
  39. Korbet SM, Volpini KC, Whittier WL. Percutaneous renal biopsy of native kidneys: a single-center experience of 1,055 biopsies. Am J Nephrol. 2014;39(2):153-162. https://doi.org/10.1159/000358334
  40. Plesset MS, Prosperetti A. Bubble dynamics and cavitation. Annu Rev Fluid Mech. 1977;9:145-185. https://doi.org/10.1146/annurev.fl.09.010177.001045
  41. Mleczko M, Postema M, Schmitz G. Discussion of the application of finite Volterra series for the modeling of the oscillation behavior of ultrasound contrast agents. Appl Acoust. 2009;70:1363-1369. https://doi.org/10.1016/j.apacoust.2008.09.012
  42. Postema M, van Wamel A, ten Cate FJ, de Jong N. High-speed photography during ultrasound illustrates potential therapeutic applications of microbubbles. Med Phys. 2005;32(12):3707-3711. https://doi.org/10.1118/1.2133718
  43. Zeccolini G, Del Biondo D, Cicero C, Casarin A, Guarise A, Celia A. Comparison of Contrast-Enhanced Ultrasound Scan (CEUS) and MRI in the follow-up of cryoablation for small renal tumors. Experience on 25 cases. Urologia. 2014;81(Suppl.23):S1-8. https://doi.org/10.5301/ru.2014.11986
  44. Konopke R, Kersting S, Bergert H, Bloomenthal A, Gastmeier J, Saeger HD, Bunk A. Contrast-enhanced ultrasonography to detect liver metastases: a prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy. Int J Colorectal Dis. 2007;22(2):201-207. https://doi.org/10.1007/s00384-006-0134-5
  45. Torzilli G. Contrast-enhanced intraoperative ultrasonography in surgery for liver tumors. Eur J Radiol. 2004;51(Suppl.):S25-S29. https://doi.org/10.1016/j.ejrad.2004.03.025
  46. Cosgrove D, Lassau N. Assessment of tumour angiogenesis using contrast-enhanced ultrasound. J Radiol. 2009;90(1,Pt2):156-164. https://doi.org/10.1016/s0221-0363(09)70094-0
  47. Dai Y, Chen MH, Fan ZH, Yan K, Yin SS, Zhang XP. Diagnosis of small hepatic nodules detected by surveillance ultrasound in patients with cirrhosis: Comparison between contrast-enhanced ultrasound and contrast-enhanced helical computed tomography. Hepatol Res. 2008;38(3):281-290. https://doi.org/10.1111/j.1872-034x.2007.00269.x
  48. Sanz E, Hevia V, Arias F, Fabuel JJ, Álvarez S, Rodríguez-Patrón R, Gómez V, Díez-Nicolás V, González-Gordaliza C, Burgos FJ. Contrast-enhanced ultrasound (CEUS): an excellent tool in the follow-up of small renal masses treated with cryoablation. Curr Urol Rep. 2015;16(1):469. https://doi.org/10.1007/s11934-014-0469-3
  49. Bolte SL, Ankem MK, Moon TD, Hedican SP, Lee FT, Sadowski EA, Nakada SY. Magnetic resonance imaging findings after laparoscopic renal cryoablation. Urology. 2006;67(3):485-489. https://doi.org/10.1016/j.urology.2005.09.015
  50. Miki K, Shimomura T, Yamada H, Kishimoto K, Ohishi Y, Harada J, Egawa S. Percutaneous cryoablation of renal cell carcinoma guided by horizontal open magnetic resonance imaging. Int J Urol. 2006;13(7):880-884. https://doi.org/10.1111/j.1442-2042.2006.01432.x
  51. Shingleton WB, Sewell PE Jr. Cryoablation of renal tumours in patients with solitary kidneys. BJU Int. 2003;92(3):237-239. https://doi.org/10.1046/j.1464-410x.2003.04322.x
  52. Caviezel A, Terraz S, Schmidlin F, Becker C, Iselin CE. Percutaneous cryoablation of small kidney tumours under magnetic resonance imaging guidance: medium-term follow-up. Scand J Urol Nephrol. 2008;42(5):412-416. https://doi.org/10.1080/00365590801951632
  53. Kong WT, Zhang WW, Guo HQ, Qiu JL, Tang M, Jiang ZM, Shen Y, Li XG, Zhang SW. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response? Abdom Imaging. 2011;36(3):342-347. https://doi.org/10.1007/s00261-010-9665-x
  54. Meloni MF, Bertolotto M, Alberzoni C, Lazzaroni S, Filice C, Livraghi T, Ferraioli G. Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: contrast-enhanced sonography versus contrast-enhanced CT or MRI. AJR Am J Roentgenol. 2008;191(4):1233-1238. https://doi.org/10.2214/ajr.07.3238
  55. Grossjohann HS. Contrast-enhanced ultrasound for diagnosing, staging and assessment of operability of pancreatic cancer. Dan Med J. 2012;59(12):B4536. https://doi.org/10.3390/diagnostics2020002
  56. Lu Q, Zhong XF, Huang ZX, Yu BY, Ma BY, Ling WW, Wu H, Yang JY, Luo Y. Role of contrast-enhanced ultrasound in decision support for diagnosis and treatment of hepatic artery thrombosis after liver transplantation. Eur J Radiol. 2012;81(3):e338-e343. https://doi.org/10.1016/j.ejrad.2011.11.015
  57. Guang Y, Xie L, Ding H, Cai A, Huang Y. Diagnosis value of focal liver lesions with SonoVue-enhanced ultrasound compared with contrast-enhanced computed tomography and contrast-enhanced MRI: a meta-analysis. J Cancer Res Clin Oncol. 2011;137(11):1595-1605. https://doi.org/10.1007/s00432-011-1035-8
  58. Lu MD, Yu XL, Li AH, Jiang TA, Chen MH, Zhao BZ, Zhou XD, Wang JR. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China. Ultrasound Med Biol. 2007;33(11):1736-1749. https://doi.org/10.1016/j.ultrasmedbio.2007.05.004
  59. Hu Q, Wang XY, Zhu SY, Kang LK, Xiao YJ, Zheng HY. Meta-analysis of contrast-enhanced ultrasound for the differentiation of benign and malignant breast lesions. Acta Radiol. 2015;56(1):25-33. https://doi.org/10.1177/0284185113517115
  60. Zhao X, Wang W, Zhang S, Liu J, Zhang F, Ji C, Li X, Gan W, Zhang G, Guo H. Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients. Abdom Imaging. 2012;37(5):885-891. https://doi.org/10.1007/s00261-011-9828-4
  61. Efremova I, Mitina L, Sinelnikova A, Skupchenko A, Skobeltsov D. Effectiveness of contrast enhanced ultrasound examination after radiofrequency ablation liver metastasis. Ultraschall Med. 2016;37:PS1_04. https://doi.org/10.1055/s-0036-1587819.
  62. Stepanov SO, Mitina LA, Kazakevich VI, Kaprin AD, Alekseev BYa, Kostin AA, Skreptsova NS, Guts OV, Prozorova EV. Ul’trazvukovaya diagnostika ochagovykh obrazovanii v pecheni s ispol’zovaniem kontrastnogo preparata Sonov’yu. Metodicheskie rekomendatsii. Moscow: MNIOI im. P.A. Gertsena — filial FGBU «NMIRTs» Minzdrava Rossii; 2015:3-6. (In Russ.)
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.